Vitiligo and other hypopigmentation disorders in children and adolescents


  • Sonja Prćić Institute for Health Care of Children and Youth of Vojvodina, Medical Faculty of University of Novi Sad, Novi Sad
  • Verica Đuran Clinic for Skin and Venereal Diseases Clinical Center of Vojvodina, Medical Faculty of University of Novi Sad
  • Dragan Katanić Institute for Health Care of Children and Youth of Vojvodina, Medical Faculty of University of Novi Sad, Novi Sad


Hypopigmentation, Vitiligo, Child, Adolescent, Diagnosis


Th e loss of pigment, either partial (hypopigmentation) or complete(depigmentation), can have a major psychological impact on patients.Hypopigmentation disorders, congenital and acquired, are very numerous,and many of them are rarely seen. Th is paper provides anoverview of the most common hypopigmentation disorders in childrenand adolescents, stressing the importance of vitiligo and autoimmunedisorders in patients. Vitiligo is an acquired disease, possibly ofautoimmune nature, sometimes with a clear hereditary component,which is characterized by progressive, clearly defi ned, milky whitespots on the skin and/or mucous membranes. In about 50% of patientsvitiligo occurs before 20 years of age. Th e clinical picture of vitiligo inchildren and adolescents is similar to adults, but there are some differencesin the epidemiology, their associations with other endocrineand/or autoimmune diseases and treatment of vitiligo in childrencompared to adult patients.


Download data is not yet available.


Ortonne JP, Bahdoran P, Fitzpatrick TB, Mosher DB, Hori Y. Hypomelanoses and hypermelanoses. In: Fitzpatrick TB, Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, eds. Fitzpatrick’s Dermatology in general medicine. 6th ed, New York: Mc Graw-Hill Proff esional; 2003. p. 839-47.

Pavlović MD. Poremećaji pigmentacije. U: Karadaglić Đ. Dermatologija. Beograd: Vojnoizdavački zavod; 2000. p. 871-902.

Kovacs SO. Vitiligo. J Am Acad Dermatol. 1998;38:647-66.

Huggins RH, Schwartz RA, Janniger CK. Vitiligo. Acta Dermatoven APA. 2005;4(14): 137-45.

Schmid-Ott G, Kunsebeck HW, Jecht E, Shimshoni R, Lazaroff I, Schallmayer S, et al. Stigmatization experience, coping and sense of coherence in vitiligo patients. J Eur Acad Dermatol Venereol. 2007;46:990-5.

Lio PA. Little white spots: an approach to hypopigmented macules. Arch Dis Child Ed Pract. 2008;93:98-102.

Halder RM. Childhood vitiligo. Clin Dermatol. 1997;15:899-906.

Hurwitz S. Disorders of pigmentation. In: Hurwitz S. Clinical pediatric dermatology. Philadelphia: W. B. Saunders Company; 1993. p.458-60.

Janniger CK. Childhood vitiligo. Cutis. 1993;51:25-8.

Handa S, Dogra S. Epidemiology of childhood vitiligo: a study of 625 patients from north India. Pediatr Dermatol. 2003;20:207-10.

Huggins RH, Schwartz RA, Janniger CK. Childhood vitiligo. Cutis Cutaneous Medicine For The Practitioner. 2007;79(4):277-80.

Prcic S, Djuran V, Katanic D. Vitiligo in children and adolescents: a literature review. Serb J Dermatol Venereol. 2010;2(3):95-104.

Deng GY, Muir A, Maclaren NK, She JX. Association of LMP2 and LMP7 gnes within MHC with insulin-dependent diabetes mellitus: population and family studies. Am J Hum Gen. 1995;56:528-34.

Arcos-Burgos M, Parodi E, Salgar M, Bedoya E, Builes J, Jaramillo D, et al. Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatelite loci spanning the HLA. Hum Genet. 2002;110:334-42.

Zamani M, Spaepen M, Sghar SS, Huang C, Westerhof W, Nieuweboer-Krobotova L, et al. Linkage and association of HLA class II genes with vitiligo in a Dutch population. Br J Dermatol. 2001;145:90-4.

Ando I, Chi HI, Nakagawa H, Otsuka F. Diff erence in clinical features and HLA antigenes between familial and non-familial vitiligo of non-segmental type. Br J Dermatol. 1993;129:408-10.

Pajvani U, Ahmad N, Wiley A, Levy RM, Kundu R, Mancini AJ, et al. Th e relationship between family medical history and childhood vitiligo. J Am Acad Dermatol. 2006;55(2):238-44.

Prahalad S, Kingsbury DJ, Griffi n TA, Cooper BL, Glass DN, Maksimowych WP, et al. Polymorphism in the MHC- encoded LMP7 gene: association with JRA without functional signifi cance for immunoproteasome assembly. J Rheumatol. 2001;


Njoo MD, Westerhof W. Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol. 2001;2(3):167-81.

Taieb A. Intrinsic and extrinsic pathomechanismus in vitiligo. Pigment Cell Res. 2000;13 Suppl:841-7.

Kemp EH, Waterman EA, Weetman AP. Autoimmune aspects of vitiligo. Autoimmunity. 2001;34:653.

Alkhateeb A, Fain RP, Th ody A, Bennett CD, Spritz RA. Epidemiology of vitiligo and associated autoimmune diseases in Causian probands and their families. Pigment Cell Res. 2003;16 Suppl:208-14.

Fain PR, Gowan K, La berge GS, Alkhateeb A, Stetler GL, Talbert J, et al. A genomewide screen for generalized vitiligo: confi rmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet. 2003;72:1560-4.

Alkhateeb A, Stetler GL, Old W, Talbert J, Unihorn C, Taylor M, et al. Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p.32.2. Hum Mol Genet.2002;11:661-7.

Jin Y, Mailloux CM, Gowan K, Riccardi SL, La-Berge G, Bennett DC, et al. NALP 1 in vitiligo-associated multiple autoimmune disease. N Engl J Med. 2007;356:1216-25.

Passi S, De Luca S, Stancato A, Maggro F, Grandinetti M. Epidermal oxidative stress in vitiligo. Pigment Cell Res. 1998;11:81-5.

Gauthier Y, Cario Andre M, Taieb A. A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res. 2003;16:322-32.

Liu PY, Johansson O, Loutz W, Bondesson L. The occurrence of cutaneous nerve endings and neuropeptides in vitiligo vulgaris: a case-control study. Arch Dermatol Res. 1996;288:670-5.

Cho S, Kang HC, Hahm JH. Characteristics of vitiligo in Korean children. Pediatr Dermatol. 2000; 17:189-93.

Zhi H, Jiang-Bo L, Sui- Sui M, Sen Yang, Xue- Jun Z. Profile of childhood vitiligo in China: an analysis of 541 patients. Pediatr Dermatol. 2006; 23(2):114-6.

Al-Mutairi N, Sharma AK, Al-Sheltawy M, Nour-Eldin O. Childhood vitiligo: a prospective hospital-based study. Aust J Dermatol. 2005; 46:150-3.

Prcic S, Duran V, Mikov A, Mikov I. Vitiligo in children. Pediatr Dermatol. 2007;24(6):666.

Hegedus L, Heidenheim M, Gevril M, Hjalgrim H, Hoiert-Madsen M. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol. 1994;74:120-3.

Zetting G, Tanew A, Fisher G, Mayr W, Dudczak R, Weissel M. Autoimmune diseases in vitiligo: do antinuclear antibodies decrease thyroid volume? Clin Exp Immunol. 2003;131:347-54.

Schallreuter KU, Lemke R, Brandt O, Schwartz R, Westhofen M, Montz R, Berger J. Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology. 1994;l88:269-75.

Iacovelli P, Sinagra J, Paro Vidolin A, Marenda S, Capitanio B, Leone G, et al. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology. 2005;210:26-30.

Kakourou T, Kanaka-Gantenbein C, Papadopoulou A, Kaloumenou E, Chrousous G. Increased prevalence of chronic autoimmune (Hashimoto’s) thyroiditis in children and adolescents with vitiligo. J Am Acad Dermatol. 2005;220-3.

Prćić S. ¨Vitiligo i poremećaji funkcije štitaste žlezde kod dece i adolescenata¨. Doktorska teza. Novi Sad, Srbija: Medicinski fakultet Univerziteta u Novom Sadu: 2009.

Parsad D, Pandhi R, Dogra S, Kumar B. Clinical study of repigmentation patterns with different treatments modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches. J Am Acad Dermatol. 2004;50:63-7.

Grimes PE. Whites patches and bruised souls: advances in pathogenesis and treatment of vitiligo. J Am Acad Dermatol. 2004;51:85-7.

Njoo MD, Bos JD, Westerhof W. Treatment of generalised vitiligo in children with narrow-band (TL-01) UVB radiation therapy. J Am Acad Dermatol. 2000;245-3.

Hadi SM. Spencer JM. Lebwohl M. The use of 308-nm excimer laser for the treatment of vitiligo. Dermatol Surg. 2004;140:677-83.

Xu AE, Wei XD. Topical melagenine for repigmentation in twenty-two child patients with vitiligo on the scalp. Chinese Med J. 2004;117:199-201.

Silverberg NB, Lin P, Travis L, Farley-Li J, Mancini AJ, Wagner AM, et al.. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J Am Acad Dermatol.


Gargoom AM, Duweb GA, Elzorghany AH, Benghazil M, Bugrein OO. Calcipotriol in the treatment of childhood vitiligo. Int J Clin Pharmacol Res. 2004;24:11-4.

Gupta S, Kumar B. Epidermal graft ing for vitiligo in adolescents. Pediatr Dermatol. 2002;19:159-62.

Tedeshi A, Dall Oglio F, Micali G, Schwartz RA, Janniger CK. Corrective camoufl age in pediatric dermatology. Cutis. 2007;79:110-2.

Richie L, Janniger C. Pityriasis alba. Cutis Cutaneous Medicine For Th e Practitioner. 2005;76:21-4.

Nelson MM, Martin AG, Hefernan MP. Fungal diseases with cutaneous involment. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, eds. Fitzpatrick ‘s Dermatology in general medicine. 6th ed, New York: Mc Graw-Hill Proffesional; 2003. p. 1989-2034.

Schwartz R, Fernandez G, Kotylska K, Jozwiak S. Tuberous sclerosis complex: advances in diagnosis, genetics, and management. J Am Acad Dermatol. 2007:189-202.




How to Cite

Prćić, S., Đuran, V., & Katanić, D. (2011). Vitiligo and other hypopigmentation disorders in children and adolescents. Acta Medica Academica, 40(2), 174–181. Retrieved from



Review Articles

Similar Articles

You may also start an advanced similarity search for this article.